BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Antigen Discovery Inc. 

One Technology Drive
Suite E309
Irvine  California  92618  U.S.A.
Phone: 949-679-4068 Fax: 949-679-4069


SEARCH JOBS




Industry
Biotechnology

Segment
Vaccines





 Company News
Antigen Discovery Inc. Awarded Phase I SBIR Grant to Develop a Fully Integrated Microfluidic Point of Care Diagnostic Device 8/16/2012 9:34:09 AM    More...
Diagnostics Platform Coming to Your Smartphone, Antigen Discovery Inc. Reveals 8/16/2012 8:01:10 AM    More...
Antigen Discovery Inc. Awarded Phase II SBIR Grant to Identify Biomarkers Associated With Protection Against Malaria 8/13/2012 9:48:38 AM    More...
Antigen Discovery Inc. Awarded Grant for Chlamydia Vaccine Development The World's Most Prevalent Sexually-Transmitted Bacteria Phase II STTR from the National Institute of Allergy and Infectious Diseases 9/21/2009 9:31:55 AM    More...
Juvaris BioTherapeutics Announces Strategic Collaboration with Antigen Discovery Inc. 6/29/2009 12:06:23 PM    More...
Antigen Discovery Inc. Awarded a SBIR Phase II Grant to Commercialize Novel Antigens for Serodiagnostic Products and Vaccine Development 7/3/2008 7:55:17 AM    More...